Published in J Immunol on June 15, 2007
Th17 cells in human disease. Immunol Rev (2008) 4.27
Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 3.65
Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol (2009) 1.95
T cells as therapeutic targets in SLE. Nat Rev Rheumatol (2010) 1.75
Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J Immunol (2009) 1.59
Th17 cytokines and arthritis. Semin Immunopathol (2010) 1.57
Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol (2010) 1.54
Tolerogenic plasmacytoid DC. Eur J Immunol (2010) 1.48
Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice. Genes Immun (2011) 1.41
Th17 cells in immunity and autoimmunity. Clin Dev Immunol (2013) 1.40
Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med (2008) 1.38
Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res Ther (2008) 1.31
Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. Clin Dev Immunol (2012) 1.27
Regulatory dendritic cells: there is more than just immune activation. Front Immunol (2012) 1.25
IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol (2008) 1.24
Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr Opin Rheumatol (2011) 1.19
Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol (2011) 1.16
The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res (2011) 1.14
Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol (2010) 1.10
Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells. Lupus (2009) 1.08
Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res Ther (2011) 1.05
The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther (2010) 1.04
IL-17 in systemic lupus erythematosus. J Biomed Biotechnol (2010) 1.04
CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells. Cell Mol Immunol (2010) 1.04
Cytokines in systemic lupus erythematosus. Curr Mol Med (2009) 1.03
Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int (2011) 1.02
An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS One (2010) 1.02
Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J Immunol (2011) 1.00
The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin Rheumatol (2010) 0.99
Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog (2013) 0.99
Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus. Clin Dev Immunol (2012) 0.98
Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin Biol Ther (2009) 0.98
Lupus nephritis: current update. Arthritis Res Ther (2011) 0.97
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med (2011) 0.97
Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. J Autoimmun (2011) 0.96
IL-17 in the rheumatologist's line of sight. Biomed Res Int (2013) 0.95
Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity. Front Immunol (2013) 0.95
Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol (2014) 0.94
Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation. PLoS One (2011) 0.94
Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther (2009) 0.92
Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients. Clin Exp Med (2011) 0.90
Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis. Immunology (2009) 0.87
Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1 mice. Birth Defects Res A Clin Mol Teratol (2009) 0.86
The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity. Thromb Haemost (2011) 0.85
Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens. J Immunol (2012) 0.85
Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells. Photodermatol Photoimmunol Photomed (2011) 0.85
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice. Hum Immunol (2008) 0.83
A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide. J Clin Immunol (2009) 0.83
Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy. J Biomed Biotechnol (2010) 0.82
Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells. Nat Clin Pract Rheumatol (2008) 0.82
The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms. J Clin Immunol (2011) 0.82
Genes, tolerance and systemic autoimmunity. Autoimmun Rev (2011) 0.82
Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane. Clin Exp Immunol (2014) 0.81
Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity. Clin Immunol (2013) 0.81
The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Arthritis (2011) 0.81
Suppressive oligodeoxynucleotides promote the development of Th17 cells. PLoS One (2013) 0.80
Modulatory function of invariant natural killer T cells in systemic lupus erythematosus. Clin Dev Immunol (2012) 0.80
Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells. Clin Exp Immunol (2014) 0.80
Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus? Clin Immunol (2008) 0.79
Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells. J Immunol Res (2016) 0.78
Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity. Arthritis Res Ther (2008) 0.78
Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice. J Autoimmun (2014) 0.78
Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy. Clin Rheumatol (2014) 0.77
Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B. Clin Exp Immunol (2016) 0.77
Designing the optimal vaccine: the importance of cytokines and dendritic cells. Open Vaccine J (2010) 0.77
HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells. PLoS Pathog (2016) 0.76
Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases. Clin Dev Immunol (2011) 0.75
Drugs in early clinical development for Systemic Lupus Erythematosus. Expert Opin Investig Drugs (2016) 0.75
Tolerogenic dendritic cells induced by BD750 ameliorate proinflammatory T cell responses and experimental autoimmune encephalitis in mice. Mol Med (2017) 0.75
HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog (2009) 2.15
Functional equivalence and evolutionary convergence in complex communities of microbial sponge symbionts. Proc Natl Acad Sci U S A (2012) 1.63
Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus. Arthritis Rheum (2007) 1.60
CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol (2004) 1.56
The accuracy of dermatology network physician directories posted by Medicare Advantage health plans in an era of narrow networks. JAMA Dermatol (2014) 1.50
Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med (2004) 1.47
Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol (2005) 1.39
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant (2011) 1.37
Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J Immunol (2002) 1.17
Marine microbial symbiosis heats up: the phylogenetic and functional response of a sponge holobiont to thermal stress. ISME J (2013) 1.12
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction. J Pharmacol Exp Ther (2012) 1.11
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation. Gastroenterology (2009) 1.05
Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med (2002) 1.03
Gender and ethnic differences in the prevalence of type 2 diabetes among Asian subgroups in California. J Diabetes Complications (2013) 0.96
Distinct T cell recognition of naturally processed and cryptic epitopes within the immunodominant 35-55 region of myelin oligodendrocyte glycoprotein. J Neuroimmunol (2006) 0.95
Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther (2009) 0.92
Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway. Immunol Lett (2008) 0.88
A defect in deletion of nucleosome-specific autoimmune T cells in lupus-prone thymus: role of thymic dendritic cells. J Immunol (2005) 0.88
Ankyrin-repeat proteins from sponge symbionts modulate amoebal phagocytosis. Mol Ecol (2013) 0.87
Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens. J Immunol (2012) 0.85
Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib. Australas J Dermatol (2013) 0.83
Efficacy of a jellyfish sting inhibitor in preventing jellyfish stings in normal volunteers. Wilderness Environ Med (2004) 0.83
Regulatory T cells in lupus. Int Rev Immunol (2006) 0.83
The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms. J Clin Immunol (2011) 0.82
Harnessing single cell sorting to identify cell division genes and regulators in bacteria. PLoS One (2013) 0.82
Direct synthesis of branched gold nanocrystals and their transformation into spherical nanoparticles. J Phys Chem B (2006) 0.82
Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity. Clin Immunol (2013) 0.81
Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease. J Med Chem (2014) 0.81
Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction (2015) 0.80
pH-driven assembly of various supported lipid platforms: a comparative study on silicon oxide and titanium oxide. Langmuir (2011) 0.80
Do patients with inflammatory bowel disease want genetic testing? Inflamm Bowel Dis (2006) 0.79
Arteriovenous malformation: a potential cause of ischaemic colitis. ANZ J Surg (2013) 0.79
Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality? Clin Cardiol (2014) 0.78
Discovery of lead compounds targeting the bacterial sliding clamp using a fragment-based approach. J Med Chem (2014) 0.75
Clinical Practice Guideline: Safe Medication Use in the ICU. Crit Care Med (2017) 0.75
Genetic origin of lupus in NZB/SWR hybrids: lessons from an intercross study. Arthritis Rheum (2005) 0.75
Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU. Crit Care Med (2017) 0.75
B cell stimulatory effects of alpha-enolase that is differentially expressed in NZB mouse B cells. Clin Immunol (2002) 0.75
Prognostic value of initial elevation in cardiac troponin I level in critically ill patients without acute coronary syndrome. Crit Care Nurse (2015) 0.75
Gender and Ethnic Diversity in Academic PM&R Faculty: National Trend Analysis of Two Decades. Am J Phys Med Rehabil (2017) 0.75